160 related articles for article (PubMed ID: 1594386)
1. Liposomal amphotericin-B (AmBisome) for treatment of disseminated fungal infections in two infants of very low birth weight.
Lackner H; Schwinger W; Urban C; Müller W; Ritschel E; Reiterer F; Kuttnig-Haim M; Urlesberger B; Hauer C
Pediatrics; 1992 Jun; 89(6 Pt 2):1259-61. PubMed ID: 1594386
[No Abstract] [Full Text] [Related]
2. Which is the most appropriate dosage of liposomal Amphotericin-B (AmBisome) for the treatment of fungal infections in infants of very low birth weight?
da Silva LP; Amaral JM; Ferreira NC
Pediatrics; 1993 Jun; 91(6):1217-8. PubMed ID: 8502538
[No Abstract] [Full Text] [Related]
3. Liposomal amphotericin B in neonates with invasive candidiasis.
Al Arishi H; Frayha HH; Kalloghlian A; Al Alaiyan S
Am J Perinatol; 1998; 15(11):643-8. PubMed ID: 10064206
[TBL] [Abstract][Full Text] [Related]
4. Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
Santos RP; Sánchez PJ; Mejias A; Benjamin DK; Walsh TJ; Patel S; Jafri HS
Pediatr Infect Dis J; 2007 Apr; 26(4):364-6. PubMed ID: 17414408
[TBL] [Abstract][Full Text] [Related]
5. Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight.
Frankenbusch K; Eifinger F; Kribs A; Rengelshauseu J; Roth B
J Perinatol; 2006 Aug; 26(8):511-4. PubMed ID: 16871222
[TBL] [Abstract][Full Text] [Related]
6. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data.
Ng TT; Denning DW
Arch Intern Med; 1995 May; 155(10):1093-8. PubMed ID: 7748054
[TBL] [Abstract][Full Text] [Related]
7. Systemic candidiasis in very low-birth-weight infants (less than 1,500 grams).
Johnson DE; Thompson TR; Green TP; Ferrieri P
Pediatrics; 1984 Feb; 73(2):138-43. PubMed ID: 6694869
[TBL] [Abstract][Full Text] [Related]
8. Amphotericin B dosage for disseminated candidiasis in premature infants.
Hall JE; Cox F; Karlson K; Robertson A
J Perinatol; 1987; 7(3):194-8. PubMed ID: 3332892
[TBL] [Abstract][Full Text] [Related]
9. Candida albicans meningitis in a 27 weeks premature infant treated with liposomal amphotericin-B (AmBisome).
Jarløv JO; Born P; Bruun B
Scand J Infect Dis; 1995; 27(4):419-20. PubMed ID: 8658084
[TBL] [Abstract][Full Text] [Related]
10. Nanosomal Amphotericin B is an efficacious alternative to Ambisome for fungal therapy.
Sheikh S; Ali SM; Ahmad MU; Ahmad A; Mushtaq M; Paithankar M; Mandal J; Saptarishi D; Sehgal A; Maheshwari K; Ahmad I
Int J Pharm; 2010 Sep; 397(1-2):103-8. PubMed ID: 20621173
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous aspergillosis in a preterm infant.
Perzigian RW; Faix RG
Am J Perinatol; 1993 Jul; 10(4):269-71. PubMed ID: 8397559
[TBL] [Abstract][Full Text] [Related]
12. High cure rate of invasive fungal infections in immunocompromised children using ambisome.
Ringdén O; Tollemar J; Dahllöf G; Tydén G
Transplant Proc; 1994 Feb; 26(1):175-7. PubMed ID: 8108927
[No Abstract] [Full Text] [Related]
13. [Liposome amphotericin in the treatment of deep mycoses in patients not severely immunosuppressed. An efficient alternative with low toxicity].
Fernández B de Quirós J; Telenti M; Fernández Castro A; Mateos V; Arnáez Moral E
Med Clin (Barc); 1993 Oct; 101(11):421-3. PubMed ID: 8231358
[TBL] [Abstract][Full Text] [Related]
14. Successful medical treatment of Candida parapsilosis endocarditis in a premature infant.
Faix RG; Feick HJ; Frommelt P; Snider AR
Am J Perinatol; 1990 Jul; 7(3):272-5. PubMed ID: 2372336
[TBL] [Abstract][Full Text] [Related]
15. [Sepsis by Candida in VLBW neonates: therapy with liposomal Amphotericin B].
Occhipinti E; Caravello T; Ciminello N; Di Pietro A; Lima G; Machì A; Raia GM; Scarfia MF; Spinto C; Vaccaro PG; Rizzo A
Pediatr Med Chir; 2004; 26(1):57-60. PubMed ID: 15529814
[TBL] [Abstract][Full Text] [Related]
16. [Neonatal candidiasis and liposomal amphotericin B treatment: our experience].
Carrasco Sánchez P; Castillo Montero ML; Bejarano Palma A; López Sanz A; Santano Gallinato M; Sáenz Reguera C; Durán de Vargas L; González-Meneses A
An Esp Pediatr; 1999 Sep; 51(3):273-80. PubMed ID: 10575751
[TBL] [Abstract][Full Text] [Related]
17. Treatment of neonatal candidiasis with liposomal amphotericin B(L-AMP-LRC-1): phase II study.
Kotwani RN; Bodhe PV; Kirodian BG; Mehta KP; Ali US; Kshirsagar NA
Indian Pediatr; 2003 Jun; 40(6):545-50. PubMed ID: 12824664
[TBL] [Abstract][Full Text] [Related]
18. Liposomal amphotericin-B as a therapeutic measure to control experimental aspergillosis in BALB/c mice.
Ahmad I; Sarkar AK; Bachhawat BK
Indian J Biochem Biophys; 1990 Dec; 27(6):370-4. PubMed ID: 2102483
[No Abstract] [Full Text] [Related]
19. Aspergillus fumigatus Meningitis in a Preterm.
Phute SU; Bhakre JB
Indian Pediatr; 2010 Nov; 47(11):980. PubMed ID: 21149907
[No Abstract] [Full Text] [Related]
20. Liposomal amphotericin B (AmBisome) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis.
Cordonnier C; Bresnik M; Ebrahimi R
Mycoses; 2007 May; 50(3):205-9. PubMed ID: 17472618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
